Kite Pharma (KITE) Debt to Equity Ratio
Current and historical debt to equity ratio values for Kite Pharma (KITE) over the last 10 years.
|Medical||Medical - Biomedical and Genetics||$10.285B||$0.022B|
|Kite Pharma, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of cancer immunotherapy products. The Company is developing a pipeline of eACT-based product candidates for the treatment of solid and hematological malignancies. Kite Pharma, Inc. is headquartered in Santa Monica, California.|